CCR Down Under is barely over and we now turn our focus back to Belfast for CCR26, June 10th to 12th, 2026.

Over the rest of December we'll announce the the major trial results to be presented at Titanic Belfast.

Our 10th trial is ABC post-ICU, a multicentre randomised trial investigating whether active treatment of anaemia after intensive care unit discharge can improve recovery in ICU survivors. Adult patients with haemoglobin ≤94 g/L at the point of ICU discharge are randomised to either usual restrictive transfusion care or a more liberal strategy using single-unit red blood cell transfusions targeting a haemoglobin of 100–120 g/L during the remainder of the hospital stay. The trial focuses on patient-centred outcomes, with the primary endpoint being physical health-related quality of life measured by the SF-36 Physical Component Summary score at 90 days. Secondary outcomes include fatigue, disability, mental health, mortality, transfusion safety, and cost-effectiveness, assessed out to 180 days. By shifting transfusion practice beyond the ICU, ABC post-ICU addresses a major evidence gap in post-critical illness recovery and post-intensive care syndrome.

Registration for CCR26 opens soon!

Added December 31st